Dr. Maki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-0946Fax+1 608-263-9103- Is this information wrong?
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 1973 - 1974
- Boston University Medical CenterResidency, Internal Medicine, 1972 - 1973
- Massachusetts General HospitalResidency, Internal Medicine, 1971 - 1972
- Boston University Medical CenterResidency, Internal Medicine, 1967 - 1969
- University of Wisconsin School of Medicine & Public HealthClass of 1967
Certifications & Licensure
- IL State Medical License 2010 - 2026
- WI State Medical License 1974 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection Start of enrollment: 2007 Jan 01
Publications & Presentations
PubMed
- Emerging data in COVID-19 create urgent challengers for health providers: Updates on COVID-19 vaccine and Paxlovid.Maria Carmenza Mejia, John Mitchell, Meghana Dumpa, Dennis G Maki, Mark DiCorcia, Robert S Levine, Charles H Hennekens> ;Journal of the National Medical Association. 2024 Apr 1
- In complicated UTI or pyelonephritis, cefepime-enmetazobactam increased success vs. piperacillin-tazobactam at 14 d.Dennis G Maki> ;Annals of Internal Medicine. 2023 Feb 1
- 2 citationsNaloxone Over the Counter: Increasing Opportunities and Challenges for Health Providers.Amalia D Ardeljan, Benjamin Fiedler, Lawrence Fiedler, George R Luck, Dennis G Maki, Lisa Clayton, Charles H Hennekens, Allison Ferris> ;The American Journal of Medicine. 2023 Jun 1
- Join now to see all
Press Mentions
- New Oral Antiviral Drug Reduces Death in Early COVID-19May 11th, 2022
- New Oral Antiviral Drug Reduces Deaths in Early COVID-19May 11th, 2022
- ‘Prescribe Ivermectin for COVID-19 Only in Large-Scale Randomized Trials’February 16th, 2022
- Join now to see all
Hospital Affiliations
- University HospitalMadison, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: